Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Jones, MD
University of Glasgow
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beatson West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom
- Wales Cancer Trials Unit
Cardiff, Wales, United Kingdom
- Ayr Hospital
Ayr, United Kingdom
- Royal Bournemouth General Hospital
Bournemouth, United Kingdom
- Queens Hospital
Burton-on-Trent, United Kingdom
- Velindre Hospital
City and County of Cardiff, United Kingdom
- Western General Hospital
Edinburgh, United Kingdom
- Calderdale Royal Infirmary
Halifax, United Kingdom
- Huddersfield Royal Infirmary
Huddersfield, United Kingdom
- the Royal Lancaster Infirmary
Lancaster, United Kingdom
- St. James'S University Hospital
Leeds, United Kingdom
- Charing Cross Hospital
London, United Kingdom
- St Marys Hospital
London, United Kingdom
- the Royal Free Hospital
London, United Kingdom
- Christie Hospital
Manchester, United Kingdom
- Mount Vernon Hospital
Northwood Middlesex, United Kingdom
- Churchill Hospital
Oxford, United Kingdom
- Weston Park Hospital
Sheffield, United Kingdom
- Southampton General Hospital
Southampton, United Kingdom
- Royal Surrey County Hospital
Surrey, United Kingdom
- the Royal Marsden Hospital
Surrey, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 31 Dec 2015
- Completion
- 5 Sept 2016
- Last update posted
- 16 May 2019
- Registered enrollment
- 82
- Registry id
- NCT01191892
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.